Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bupivacaine Effectiveness and Safety in SABER Trial (BESST)

NCT01052012 is registered in ClinicalTrials.gov with Durect as lead sponsor.

NCT NCT01052012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01052012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bupivacaine Effectiveness and Safety in SABER Trial (BESST)
Lead sponsor
Durect
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2009
Completion date
September 30, 2011
Enrollment
331 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal surgery, postoperative pain